- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05782868
Expressive Writing Intervention Study
May 22, 2024 updated by: University of Wisconsin, Madison
Promoting Well-Being Through Identity Affirmation and Social Connection in TNB Adults: An Expressive Writing Intervention
This study aims to test to what extent an expressive writing intervention may reduce internalized anti-TNB (trans and nonbinary) stigma and promote well-being over time.
Trans and/or nonbinary people may take part in this study, and can expect to participate for 3 months.
Study Overview
Status
Active, not recruiting
Conditions
Detailed Description
This study aims to decrease internalized transnegativity and to promote positive and affirming thoughts and emotions related to being transgender/nonbinary through a novel four-day expressive writing intervention.
Participants will be trans/nonbinary English-speaking adults (18+) who reside in the US.
They will be randomized to one of three study conditions (control, affirming identity, affirming identity + strengthening social connection) and will be enrolled in the study for period of 3 months (baseline, four day intervention, Days 7, 30, and 90 follow up).
Study Type
Interventional
Enrollment (Actual)
117
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53705
- University of Wisconsin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 18 years of age or older
- transgender or nonbinary
- access to a phone, computer, and/or device from which they can access the surveys and daily writing session tasks
- ability to read and write English
Exclusion Criteria:
- cisgender individuals
- self-reported severe levels of psychological distress
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: TNB Identity Affirmation (IA) Condition
Participants in the IA only intervention condition will receive the same prompt for all four days of writing, a design used in expressive writing interventions to allow for deeper and continued reflection into specific thoughts and emotions.
|
Participants will read a vignette, which describes the experience and response of a young adult who experiences rejection from a close friend after a first disclosure of their gender identity.
Participants will then be asked to write in response to three prompts: 1) identify expressions of internalized transphobia in the vignette character, 2) reflect on times the participant has experienced similar feelings, 3) identify thoughts and feelings that promote and support a positive and affirming identity in contrast to negative emotions and thoughts.
|
|
Experimental: IA + Strengthening Social Connections (SSC) Condition
For participants in the IA+SSC condition, participants will complete the IA intervention on the first three days.
On the fourth day, participants will be directed to compose a brief letter.
|
Participants will read a vignette, which describes the experience and response of a young adult who experiences rejection from a close friend after a first disclosure of their gender identity.
Participants will then be asked to write in response to three prompts: 1) identify expressions of internalized transphobia in the vignette character, 2) reflect on times the participant has experienced similar feelings, 3) identify thoughts and feelings that promote and support a positive and affirming identity in contrast to negative emotions and thoughts.
Participants will be directed to compose a brief letter of gratitude to an individual to whom they have not previously expressed gratitude, and who has provided meaningful and affirming support to them as a TNB person.
|
|
Experimental: Control Condition
Expressive writing assignment, without prompts.
|
Participants in the control condition will be asked to write about the events of their day and thoughts and feelings that occurred in response to those events.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assess the feasibility of expressive writing intervention through qualitative data
Time Frame: One week post-baseline
|
Collect open-ended text responses to the following question: Considering the logistical and practical side of this study, what was your experience like completing the writing tasks this last week?
For example, did you find it easy or challenging to write for the full 20 minutes each session?
How was it writing using the device that you did, such as writing in Word and uploading to Qualtrics or writing directly in Qualtrics?
|
One week post-baseline
|
|
Assess the feasibility of expressive writing intervention by recording the number of attended writing sessions for each participant.
Time Frame: One week post-baseline
|
Analyze any differences in number of attended writing sessions for participants by condition, with each participants' attendance score ranging from 0 (none) to 4 (all).
|
One week post-baseline
|
|
Assess the acceptability of expressive writing intervention through qualitative data
Time Frame: One week post-baseline
|
Collect open-ended text responses to the following question: Emotionally, what was your experience like completing the writing sessions this last week? Did you notice any changes in your emotional experience over the course of the week? |
One week post-baseline
|
|
Effect of missed sessions on Positive and Negative Affect Scale (PANAS)
Time Frame: One week post-baseline
|
Participants' total scale scores to the Positive and Negative Affect Scale (PANAS), which can range from 10 to 50, with higher scores indicating greater positive affect (positive affect subscale) and lower scores indicating lower levels of negative affect (negative affect subscale), will be analyzed for their correlations with missed sessions and/or participant attrition, as documented through participant attendance scores, described above.
|
One week post-baseline
|
|
Assess the fidelity of expressive writing intervention
Time Frame: One week post-baseline
|
Analyze participants' writing to assess the degree to which intervention condition writing instructions were followed.
Two members of the research team will assess participants' writing and code for the presence of emotion/affect-related words (yes=1, no=0), focus on gender identity (yes=1, no=0), and advice or encouragement offered (yes=1, no=0).
Interrater agreement will be assessed.
|
One week post-baseline
|
|
Amount of time spent writing
Time Frame: One week post-baseline
|
To assess fidelity of intervention, participants will be asked to self-report how much time they spent writing each day.
Qualtrics data will also be examined to assess how many minutes participants spent in the survey.
|
One week post-baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in resilience as determined by scores on the Brief Resilience Scale (BRS)
Time Frame: Baseline to 3 months
|
Using the Brief Resilience Scale, participants will indicate the extent to which they agree with several statements on a scale of 1 to 5, where 1 = strongly disagree and 5 = strongly agree.
A higher score indicates lower resilience.
|
Baseline to 3 months
|
|
Change in state of depression, anxiety, and stress as determined by their scores on the Depression, Anxiety, and Stress Scale
Time Frame: Baseline to 3 months
|
Using the Depression Anxiety Stress Scale (DASS), participants will indicate their negative emotional states of depression, anxiety and stress on a 0-3 scale, with higher scores indicating greater degree of depression, anxiety, or stress.
|
Baseline to 3 months
|
|
Change in psychological well-being
Time Frame: Baseline to 3 months
|
Using the Psychological Well-Being Scale (PWB), participants will indicate their level of well-being on an 18 item scale, with a range of 1 to 7, where higher scores indicate greater levels of psychological well-being.
|
Baseline to 3 months
|
|
Effects of expressive writing intervention on mental health
Time Frame: Baseline to 3 months
|
Neuro-QoL short form: Two subscales with 7 (general concerns) and 8 items (fatigue), respectively.
Rated on a 1-5 scale, with higher scores indicating lower levels of quality of life in each domain.
|
Baseline to 3 months
|
|
Change in Gender Minority Stress and Resilience (GMSR)
Time Frame: Baseline to 3 months
|
GMSR: Three subscales with 8 (Pride), 8 (Internalized transphobia), and 5 (community connectedness) items respectively.
Rated on a 1-5 scale with higher scores indicating higher levels of pride, internalized transphobia, and community connectedness.
|
Baseline to 3 months
|
|
Change in satisfaction with life
Time Frame: Baseline to 3 months
|
Participants will indicate agreement with 5 items on a 1 to 7 scale, with higher scores indicating greater satisfaction with life.
|
Baseline to 3 months
|
|
Change in perception of social support
Time Frame: Baseline to 3 months
|
Using TNB Social Support, participants will report number of contacts, as well as degree of closeness with each contact on a scale of 1 to 7, with higher scores indicating greater perception of social support.
|
Baseline to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Elliot A Tebbe, PhD, LP, University of Wisconsin, Madison
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 8, 2023
Primary Completion (Actual)
May 21, 2024
Study Completion (Estimated)
August 1, 2024
Study Registration Dates
First Submitted
March 2, 2023
First Submitted That Met QC Criteria
March 21, 2023
First Posted (Actual)
March 24, 2023
Study Record Updates
Last Update Posted (Actual)
May 23, 2024
Last Update Submitted That Met QC Criteria
May 22, 2024
Last Verified
September 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2022-1711
- Protocol Version 11/28/2022 (Other Identifier: UW Madison)
- NUR/ACAD SVCS/ACAD SVCS (Other Identifier: UW Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Researchers may submit a written request to the PI to access de-identified data.
The written request should include 1) a short background to describe rationale, 2) a description of the planned analysis, and 3) planned dissemination of findings.
The PI reserves the right to approve or disapprove any request.
Only de-identified survey data will be shared.
IPD Sharing Time Frame
Data will be made available for a period of 5 years post data collection.
IPD Sharing Access Criteria
PhD prepared researcher, holds a current appointment in an institution of higher education.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Distress, Emotional
-
Peking UniversityNot yet recruitingEmotional Disorder | Emotional DistressChina
-
Universita di VeronaUniversity of Roma La SapienzaRecruitingDistress, Emotional | Distress, PsychologicalItaly
-
Boise State UniversityNational Institute of General Medical Sciences (NIGMS)Recruiting
-
Peking UniversityNot yet recruitingEmotional DistressChina
-
Peking UniversityCompleted
-
Peking UniversityNot yet recruitingEmotional DistressChina
-
Xinghua LiuNot yet recruiting
-
Peking UniversityNot yet recruitingEmotional DistressChina
-
Peking UniversityNot yet recruiting
-
The University of Hong KongNot yet recruiting
Clinical Trials on Expressive writing in response to vignette
-
Baylor College of MedicineNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedDepression | Alcohol, DrinkingUnited States
-
Memorial Sloan Kettering Cancer CenterJoan Karnell Cancer Center at PennsylvaniaCompletedBreast Cancer | Lung Cancer | Prostate Cancer | Gynecological Cancers | Lymphoma CancerUnited States
-
Boston UniversityNational Institute of Mental Health (NIMH)RecruitingStress Disorders, Post-TraumaticUnited States
-
Hospices Civils de LyonCompletedPersistent Vegetative StateFrance
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Completed
-
Kakatiya UniversityCompletedComplication | Cardiac Event | Gender DiscriminationIndia
-
University of LouisvilleCompletedFluid Responsiveness | Carotid Artery Flow Time | Passive Leg RaiseUnited States
-
Grupo Argentino de Tratamiento de la Leucemia AgudaNot yet recruitingChronic Lymphocytic Leukemia
-
Assiut UniversityNot yet recruiting
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruitingNon-small Cell Lung CancerChina